Last Updated on December 31, 2023 by The Health Master
The Drug Controller General of India (DCGI) has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said yesterday.
The DCGI’s approval came following recommendation by the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
Prakash Kumar Singh, Director, Government and Regulatory Affairs, Serum Institute of India (SII), had recently written to the DCGI for the approval of Covovax heterologous booster dose for those aged 18 years and older in view of the escalating COVID-19 pandemic situation in some countries, an official source had said.
The SEC of the CDSCO recently deliberated on the issue and had recommended for market authorisation of COVID jab Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, according to an official source.
The DCGI had approved Covovax for restricted use in emergency situations in adults on 28th December, 2021, in the 12- to 17-year-old age group on 9th March, 2022, and in children aged 7-11 years on 28th June last year subject to certain conditions.
Covovax is manufactured through technology transfer from Novavax. It has been approved by the European Medicines Agency (EMA) for conditional marketing authorisation.
It was granted Emergency Use Listing (EUL) by the World Health Organization (WHO) on 17th December, 2021.
In August 2020, the United States-based vaccine maker Novavax had announced a licence agreement with SII for the development and commercialization of NVX-CoV2373, its COVID-19 vaccine candidate in India and in low- and middle-income Countries (LMICs).
DCGI gives nod to Phase-3 Clinical Trial of Covovax Vaccine
CDSCO Panel gives nod for FDC Tamsulosin + Solifenacin
CDSCO panel gives nod for Esomeprazole Dual Release Gastro resistant Tablets
CDSCO gives approval for this Anti-diabetic drug
CDSCO gives nod to Dapagliflozin Tablets
CDSCO approves 4 more Medical Device Testing Labs (MDTL)
USFDA gives tentative approval for Levomilnacipran extended-release capsules
IPC includes dissolution test in IP: Read details
NPPA fixes retail price of 12 formulations: January 2023
Drug recall: Epinephrine API recalled due to this reason
Deadline for Medical Colleges to submit PG Admissions info: NMC
NPPA revised Retail Price of 93 scheduled formulations: January 2023
Tramadol: 3 Pharmaceutical Companies under scanner
NABL suspends accreditation of 80 laboratories
List of approved FDCs (Fixed Dose Combinations) Updated
Latest Notifications regarding Pharmaceutical
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
